644984-78-1

Basic information

• Product Name: Benzoic acid, 4-bromo-2-ethyl- (9CI)
• Synonyms: Benzoic acid, 4-bromo-2-ethyl- (9CI);4-Bromo-2-ethylbenzoic acid
• CAS NO: 644984-78-1
• Molecular Formula: C₉H₉BrO₂
• Molecular Weight: 229.07056
• Product Categories: ETHYL
• Mol File: 644984-78-1.mol
• Article Data: 24

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzoic acid, 4-bromo-2-ethyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-bromo-2-ethyl- (9CI)(644984-78-1)
• EPA Substance Registry System: Benzoic acid, 4-bromo-2-ethyl- (9CI)(644984-78-1)

Safety Data

• Hazardous Substances Data: 644984-78-1(Hazardous Substances Data)

Usage

General Description

Benzoic acid, 4-bromo-2-ethyl- (9CI) is an organic compound with the chemical formula C9H11BrO2. It is a derivative of benzoic acid, an aromatic carboxylic acid commonly used as a food preservative and in the production of various drugs and cosmetics. The additional bromine and ethyl groups enhance the compound's reactivity and solubility, making it suitable for various industrial applications. It may exhibit antimicrobial and antifungal properties, although further research is needed to fully understand its potential biological and industrial uses.

Upstream product

• 925-90-6 ethylmagnesium bromide 
• 112704-79-7 2-fluoro-4-bromobenzoic acid 
• 68837-59-2 4-bromo-2-methylbenzoic acid 
• 74-88-4 methyl iodide 
• 586-76-5 4-Bromobenzoic acid 
• 38227-87-1 2,2,6,6-tetramethylpiperidinyl-lithium 

Downstream Products

• 877131-77-6 2-(4-bromo-2-ethylbenzyl)isoindoline-1,3-dione 
• 935260-96-1 methyl 4-cyano-2-ethylbenzoate 
• 1416979-60-6 Ethyl 4-bromo-2-ethylbenzoate 
• 194487-79-1 methyl 4-bromo-2-ethylbenzoate 
• 1160707-43-6 4-bromo-2-ethyl-benzoyl chloride 
• 877131-21-0 (4-bromo-2-ethylphenyl)methanol 
• 345965-25-5 isopropyl 2-ethyl-4-bromobenzoate 
• 851335-16-5 4-(dihydroxyboranyl)-2-ethylbenzoic acid 
• 345965-18-6 benzyl 4-bromo-2-ethyl-benzoate 
• 644985-06-8 4-[4-(2-benzyl-3-oxo-cyclohex-1-enylamino)-2-ethyl-phenyl]-3-methyl-4-oxo-butyric acid methyl ester 
• 1027039-45-7 4-Bromo-5-chlorosulfonyl-2-ethyl-benzoic acid 
• 552330-86-6 5-bromoisoindolin-1-one 

Relevant articles and documents

Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases

Autoreactive B cell-derived antibodies form immune complexes that likely play a pathogenic role in autoimmune diseases. In systemic lupus erythematosus (SLE), these antibodies bind Fc receptors on myeloid cells and induce proinflammatory cytokine producti

PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS

The present invention relates to pyrimidine derivatives of formula (I) wherein (R1)n, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.